https://fenssignaling.com/inde....x.php/someone-identi
To judge the medical course of customers with Behçet uveitis after discontinuation of infliximab (IFX) therapy. Health files of eight clients just who discontinued treatment between 2010 and 2018 were retrospectively examined. The main result measures were frequency of uveitis assaults per year, best-corrected visual acuity (BCVA), aqueous flare, foveal width and fluorescein angiography (FA) scores before initiation, during treatment and after 6, 12,
Like
Comment
Share
